Advice
Supply discontinued
On 31 July 2023 the supply of buprenorphine/naloxone sublingual film (Suboxone) was discontinued and it is therefore no longer available in the UK.
Medicine details
- Medicine name:
- buprenorphine/naloxone (Suboxone)
- SMC ID:
- SMC2316
- Indication:
Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. The intention of the naloxone component is to deter intravenous misuse. Suboxone is indicated in adults and adolescents over 15 years of age who have agreed to be treated for addiction.
- Pharmaceutical company
- Indivior UK Limited
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Status
- Withdrawn
- Date advice published
- 08 February 2021
Additional notes
On 31 July 2023 the supply of buprenorphine/naloxone sublingual film (Suboxone) was discontinued and it is therefore no longer available in the UK.